Climb Bio, Inc. (CLYM): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

47.77M
As of 2025-12-31
57.44M
As of 2026-06-30
+21.6%
3-year compound annual growth
67.26M2020-12-31: 3.42M2021-12-31: 26.57M2022-12-31: 26.57M2023-12-31: 27.70M2024-12-31: 67.26M2025-12-31: 47.77M47.77M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3147.77M-29.0%2026-03-05, Balance as of period end
2024-12-3167.26M+142.8%2026-03-05, Balance as of period end
2023-12-3127.70M+4.3%2025-03-25, Balance as of period end
2022-12-3126.57M0.0%2024-03-28, Balance as of period end
2021-12-3126.57Mn/c2023-03-06, Balance as of period end
2020-12-313.42Mn/a2022-03-07, Balance as of period end